A mutation of pyruvate carboxylase in fibroblasts from a patient with severe, chronic lactic acidaemia.
Pyruvate carboxylase activity was investigated in cultured fibroblasts from a patient shown to have hepatic pyruvate carboxylase deficiency. Under standard conditions, the activity in fibroblasts was 50% of controls (p less than 0.001). Kinetic investigations of the enzyme showed abnormal protein linearity with low activity at low protein concentration. Mixture of homogenates from the patient and a control revealed no endogenous inhibitor. Temperature stability of the mutant enzyme was similar to controls. Apparent kinetic constants for the substrates bicarbonate, ATP and pyruvate were in the patient 2.6 mmol/l, 0.08 mmol/l and 0.10 mmol/l compared to 2.1 mmol/l, 0.13 mmol/l and 0.22 mmol/l in controls, respectively. The 50% inhibitory concentration of oxaloacetate was 0.5 mmol/l in controls. However, no inhibitory effect of oxaloacetate was found for pyruvate carboxylase in fibroblasts from the patient. With acetyl-CoA, the apparent activation constant was 0.21 mmol/l in controls and 0.10 mmol/l in the patient, while the Hill coefficients were similar. These results may be explained by a mutation primarily affecting the transcarboxylation site of pyruvate carboxylase from the patient.
D000138:Acidosis / Q000201:enzymology* / Q000235:genetics; D005347:Fibroblasts / Q000201:enzymology; D006801:Humans; D007700:Kinetics; D007773:Lactates / Q000097:blood*; D009154:Mutation; D010071:Oxaloacetates / Q000494:pharmacology; D011766:Pyruvate Carboxylase / Q000235:genetics*
D007773:Lactates; D010071:Oxaloacetates; D011766:Pyruvate Carboxylase